Columbus Dispatch15d
FDA approves Moderna's RSV vaccine, its second marketed product
The U.S. Food and Drug Administration has approved Moderna's respiratory syncytial virus vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
The U.S. Food and Drug Administration approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on ...
CNN15d
FDA approves Moderna’s mRNA RSV vaccine for older adults
The US Food and Drug Administration has approved another vaccine to help protect older people from respiratory syncytial virus, known as RSV. The shot, made by Moderna and sold under the name of ...
Morningstar15d
Moderna wins second product approval with RSV vaccine
First mRNA vaccine approved for a disease other than COVID Moderna Inc.'s respiratory syncytial virus vaccine for older adults received U.S. regulatory approval, the company said Friday, marking ...
CNN15d
FDA approves Moderna’s mRNA RSV vaccine for older adults
Moderna’s shot is the third RSV vaccine for people 60 and older that’s gotten the green light from the FDA and the first mRNA vaccine among them. It’s the company’s second product to ...